Chandan Healthcare Limited inaugurates second Diagnostic Centre in Ayodhya

Lucknow (Uttar Pradesh) [India], September 3: Chandan Healthcare Limited (NSE – CHANDAN), – Chandan Healthcare Limited, one of the leading players in North India’s diagnostics and healthcare services sector, has inaugurated and commenced operations at its newest unit, the Chandan Diagnostic Centre, Ayodhya. This marks the company’s second diagnostic unit in the city, highlighting its commitment to strengthening healthcare accessibility in Tier 2 and Tier 3 locations.

Positioned as a beacon of advanced medical diagnostics, the state-of-the-art facility is designed to redefine healthcare excellence by offering cutting-edge technology and comprehensive testing services. The centrecombines technological innovation with patient-centric care and aims to cater to a wide spectrum of diagnostic needs, ensuring timely and accurate results to support effective treatment plans.

The new facility is equipped with advanced diagnostic capabilities, including:

  • Digital X-Ray: Delivering precise imaging for accurate diagnosis and treatment.
  • 4-D Ultrasound: Providing high-resolution, real-time visualisation for superior insights into patient health.
  • Cardiac CT scan: Specialised scanning technology offering critical information about heart health.
  • MRI: High-quality magnetic resonance imaging for detailed studies of organs and tissues.
  • Pathological Lab Testing: A full suite of diagnostic tests to support comprehensive health evaluations.

The Chandan Diagnostic Centre has been thoughtfully designed to deliver a seamless and comfortable experience for patients, supported by skilled professionals and a compassionate approach. With this addition, Chandan Healthcare continues to advance its mission of making world-class healthcare accessible and affordable, while reinforcing its focus on expanding its footprint and delivering diagnostic excellence across India.

Commenting on the receipt of new order, Mr. Amar Singh, Promoter and Managing Director of Chandan Healthcare Limited, said, “We are pleased to announce the inauguration of our second diagnostic centre in Ayodhya, a significant step towards strengthening healthcare accessibility in Tier 2 and Tier 3 cities. This state-of-the-art facility has been designed to deliver comprehensive diagnostic services under one roof, combining cutting-edge technology with a patient-centric approach.

Equipped with advanced capabilities such as Digital X-Ray, 4-D Ultrasound, Cardiac CT, MRI and a full suite of pathological testing, the centre is positioned to provide timely and accurate results that support effective treatment plans. With this addition, we aim to redefine healthcare standards in Ayodhya and continue building a strong diagnostic network that makes world-class healthcare both accessible and affordable for communities we serve.”

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

corticobasal implants Dental Implants Ghaziabad Health Noida Oral Health prosthodontics rehab dental rohit yadav south delhi strategic implantology

Dr. Rohit Yadav — Among Delhi NCR’s Most Recognised Corticobasal® Implantologists, with 14+ Years of Experience and 25,000+ Corticobasal® Implants Placed

When Complex Cases Find a Solution: How Re-Hab Dental Is Changing Dental Implant Care Across Noida, South Delhi, and Ghaziabad Noida (Uttar Pradesh) [India], May 28: For patients across Delhi NCR who have been told that their case is “too complex”, “needs bone grafting first”, or “will take over a year”, Dr. Rohit Yadav at […]

Read More
Health

Diagnoses, Tips and Care for Dengue amid Monsoon Surge

New Delhi [India], June 01: At the peak of this monsoon season, health experts are highly recommending citizens to stay alert as the cases of dengue fever are increasing across the region. The steep rise in stagnant water areas, garbage dumps, and other unhygienic places results in a major source of mosquito breeding grounds. This […]

Read More
ashwagandha AYUSH FSSAI Health herbal_medicine india_health indian_herbs liver_toxicity nutraceuticals policy

Ashwagandha Industry Calls for Science-Led Review to Protect Farmers, Ayurveda, and India’s Nutraceutical Growth

Dr JLN Sastry, Ayurveda Consultant and Practitioner (Former CEO-NMPB) Mumbai (Maharashtra) [India], May 21: As India’s Ashwagandha sector emerges as a major pillar of the AYUSH, Ayurvedic, and nutraceutical economy, industry stakeholders are urging policymakers to adopt a science-led, product-specific approach to regulation that protects public health without undermining one of the country’s most significant […]

Read More